(Q38914271)

7 September 2017

The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer (English)

1 reference

7 September 2017

1 reference

Zhi Liu

1

1 reference

7 September 2017

Guangjing Zhu

series ordinal

2

1 reference

7 September 2017

Robert H Getzenberg

series ordinal

3

1 reference

7 September 2017

Robert W Veltri

series ordinal

4

1 reference

7 September 2017

1 July 2015

1 reference

Journal of Cellular Biochemistry

7 September 2017

1 reference

7 September 2017

116

1 reference

7 September 2017

7

1 reference

7 September 2017

1341-1349

1 reference

Multiple drug resistance mechanisms in cancer

7 September 2017

1 reference

Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly

21 January 2018

1 reference

Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer

21 January 2018

1 reference

MAP kinase signalling pathways in cancer

21 January 2018

1 reference

Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.

21 January 2018

1 reference

Taxol resistant mutants of Chinese hamster ovary cells: genetic biochemical, and cross-resistance studies.

21 January 2018

1 reference

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

Overcoming docetaxel resistance in prostate cancer: a perspective review

21 January 2018

1 reference

Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer

21 January 2018

1 reference

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere

21 January 2018

1 reference

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers

21 January 2018

1 reference

Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

21 January 2018

1 reference

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells

21 January 2018

1 reference

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

21 January 2018

1 reference

Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance

21 January 2018

1 reference

A genomic approach to identify molecular pathways associated with chemotherapy resistance

21 January 2018

1 reference

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

Transcriptional roles of PARP1 in cancer

21 January 2018

1 reference

Drug resistance in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2014

1 reference

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.

21 January 2018

1 reference

The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines

21 January 2018

1 reference

Advances in prostate cancer treatment.

21 January 2018

1 reference

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

21 January 2018

1 reference

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway

21 January 2018

1 reference

Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.

21 January 2018

1 reference

Taxol suppresses dynamics of individual microtubules in living human tumor cells

21 January 2018

1 reference

Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer

21 January 2018

1 reference

Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.25091

1 reference

7 September 2017

1 reference